Global drug makers are racing to develop and launch a coronavirus vaccine by year’s end, while lab and device firms are also piloting new methods to test patients for the virus. What’s the prognosis for manufacturing and distribution, and how are leaders navigating political pressure?
Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
This post first appeared on wsj.com
